Monica A Muñoz (Monica A Munoz, Monica Munoz, Monica Muñoz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Drug Administration

Emergency Department

Interstitial Lung Disease

Top Venues

Journal of medical Internet research

Pediatric nephrology (Berlin, Germany)

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Robert Ball, Andrew H Talal, Oanh Dang, Monica A Muñoz, Marianthi Markatou
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration. Journal of medical Internet research 26 (2024)
Robert Ball, Andrew H Talal, Oanh Dang, Monica A Muñoz, Marianthi Markatou
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration. Journal of medical Internet research 26 (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Omayma A Kishk, Ivone Kim, Carmen Cheng, Mukesh Summan, Monica A Muñoz
Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric nephrology (Berlin, Germany) 39 (8) (2024)
Omayma A Kishk, Ivone Kim, Carmen Cheng, Mukesh Summan, Monica A Muñoz
Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric nephrology (Berlin, Germany) 39 (8) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety (2024)
Omayma A Kishk, Ivone Kim, Carmen Cheng, Mukesh Summan, Monica A Muñoz
Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric nephrology (Berlin, Germany) 39 (8) (2024)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Hong Xiao, Chris Delcher, Andrew Giffin, Nabila Sadiq, Almut G Winterstein
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study. Drug safety 47 (4) (2024)
Robert Ball, Andrew H Talal, Oanh Dang, Monica A Muñoz, Marianthi Markatou
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration. Journal of medical Internet research 26 (2024)
Omayma A Kishk, Ivone Kim, Carmen Cheng, Mukesh Summan, Monica A Muñoz
Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric nephrology (Berlin, Germany) (2024)
Robert Ball, Andrew H Talal, Oanh Dang, Monica A Muñoz, Marianthi Markatou
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration. Journal of medical Internet research 26 (2024)
Michael T Phan, Carmen Cheng, Vivian Dang, Eileen Wu, Monica A Muñoz
Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study. Therapeutic innovation & regulatory science (2023)
Elizabeth A Suarez, Michael Nguyen, Di Zhang, Yueqin Zhao, Danijela Stojanovic, Monica A Muñoz, Jane Liedtka, Abby Anderson, Wei Liu, Inna Dashevsky, Sandra DeLuccia, Talia Menzin, Jennifer Noble, Judith C Maro
Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study Designs. Epidemiology (Cambridge, Mass.) 34 (1) (2022)
Elizabeth A Suarez, Michael Nguyen, Di Zhang, Yueqin Zhao, Danijela Stojanovic, Monica A Muñoz, Jane Liedtka, Abby Anderson, Wei Liu, Inna Dashevsky, David Cole, Sandra DeLuccia, Talia Menzin, Jennifer Noble, Judith C Maro
Novel Methods for Pregnancy Drug Safety Surveillance in the FDA Sentinel System. Pharmacoepidemiology and drug safety (2022)
Kathryn Marwitz, S Christopher Jones, Cindy M Kortepeter, Gerald J Dal Pan, Monica A Muñoz
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. Drug safety 43 (5) (2021)
Monica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, Chris Delcher, Hong Xiao, Cindy M Kortepeter, Almut G Winterstein
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility. Drug safety 43 (4) (2021)
Phuong Pham, Carmen Cheng, Eileen Wu, Ivone Kim, Rongmei Zhang, Yong Ma, Cindy M Kortepeter, Monica A Muñoz
Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports. Pharmaceutical medicine 35 (5) (2021)
Mohamed Mohamoud, Casie Horgan, Efe Eworuke, Elizabeth Dee, Justin Bohn, Oren Shapira, Monica A Muñoz, Danijela Stojanovic, Veronica Sansing-Foster, Adebola Ajao, Lois La Grenade
Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis. Pharmacotherapy 40 (11) (2020)
Monica A Muñoz, Gerald J Dal Pan
The Impact of Litigation-Associated Reports on Signal Identification in the US FDA's Adverse Event Reporting System. Drug safety 42 (10) (2020)
Jill K Logan, Shalini Wickramaratne Senarath Yapa, Lisa Harinstein, Bhawana Saluja, Monica A Muñoz, Chandrahas Sahajwalla, Rosemarie Neuner, Sally Seymour
Drug Interaction Between Febuxostat and Thiopurine Antimetabolites: A Review of the FDA Adverse Event Reporting System and Medical Literature. Pharmacotherapy 40 (2) (2020)